Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
134
datasets available to search
ShareScore release 0.9.0
Dataset results
134 results for “Sofosbuvir”
Effect of Sofosbuvir-daclatasuvir on Angiogenesis
ClinicalTrials.gov study NCT03646396. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy
ClinicalTrials.gov study NCT02563665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sofosbuvir in Treatment of COVID 19
ClinicalTrials.gov study NCT04460443. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT04246723. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir
ClinicalTrials.gov study NCT03247296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt
ClinicalTrials.gov study NCT04773756. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection
ClinicalTrials.gov study NCT01435044. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
ClinicalTrials.gov study NCT02705534. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
ClinicalTrials.gov study NCT04530422. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3
ClinicalTrials.gov study NCT02551861. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients
ClinicalTrials.gov study NCT04001608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)
ClinicalTrials.gov study NCT02491450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients
ClinicalTrials.gov study NCT04497649. IPD Sharing: NO. Countries: 1. Publications: 0.
Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02253550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir
ClinicalTrials.gov study NCT03855917. IPD Sharing: NO. Countries: 1. Publications: 0.
Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients
ClinicalTrials.gov study NCT02576314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
ClinicalTrials.gov study NCT02596880. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon
ClinicalTrials.gov study NCT02804386. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients
ClinicalTrials.gov study NCT04111367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNA
ClinicalTrials.gov study NCT03318887. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.